000 01299 a2200337 4500
005 20250514223522.0
264 0 _c20050524
008 200505s 0 0 eng d
022 _a0002-9149
024 7 _a10.1016/j.amjcard.2004.12.038
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchwartz, Kenneth A
245 0 0 _aCompliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction.
_h[electronic resource]
260 _bThe American journal of cardiology
_cApr 2005
300 _a973-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aArachidonic Acid
650 0 4 _aAspirin
_xadministration & dosage
650 0 4 _aDrug Resistance
650 0 4 _aHumans
650 0 4 _aMyocardial Infarction
650 0 4 _aPatient Compliance
650 0 4 _aPlatelet Aggregation Inhibitors
_xadministration & dosage
700 1 _aSchwartz, Dianne E
700 1 _aGhosheh, Khalid
700 1 _aReeves, Mathew J
700 1 _aBarber, Kimberly
700 1 _aDeFranco, Anthony
773 0 _tThe American journal of cardiology
_gvol. 95
_gno. 8
_gp. 973-5
856 4 0 _uhttps://doi.org/10.1016/j.amjcard.2004.12.038
_zAvailable from publisher's website
999 _c15489316
_d15489316